# Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis

> **NCT04085016** · — · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 98 (actual)

## Conditions studied

- Meibomian Gland Dysfunction
- Meibomitis
- Dyslipidemias

## Interventions

- **DEVICE:** Keratograph 5M, Oculus, Wetzlar, Germany

## Key facts

- **NCT ID:** NCT04085016
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-08
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04085016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04085016, "Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04085016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*